 CRESSKILL, N.J. and JERUSALEM, March 08, 2021 GLOBE NEWSWIRE -- BrainsWay Ltd. NASDAQ TASE: BWAY BrainsWay or the Company, a global leader in the advanced non-invasive treatment of brain disorders, today announced that Christopher von Jako, Ph.D., President and Chief Executive Officer, will present at the Oppenheimer 31st Annual Healthcare Conference taking place on March 16-18, 2021. The Company will also host one-on-one investor meetings at the conference. 